Related Experiment Video

Updated: Jul 30, 2025

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.6K

LRRK2 Structure-Based Activation Mechanism and Pathogenesis

Xiaojuan Zhang1, Arjan Kortholt1,2

  • 1Department of Cell Biochemistry, University of Groningen, Nijenborg 7, 9747 AG Groningen, The Netherlands.

Biomolecules
|May 16, 2023
PubMed

Insights

Mutations in Leucine-rich-repeat kinase 2 (LRRK2) are linked to Parkinson's disease (PD). Recent structural studies reveal insights into LRRK2's activation, PD mutant roles, and potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Mutations in Leucine-rich-repeat kinase 2 (LRRK2) are a significant genetic risk factor for Parkinson's disease (PD).
  • LRRK2 is a multidomain protein with enzymatic (GTPase and kinase) and regulatory domains involved in protein-protein interactions.
  • PD-associated LRRK2 mutations often alter its kinase and GTPase activities.

Purpose of the Study:

  • To review recent advancements in the structural characterization of LRRK2.
  • To discuss how structural findings illuminate LRRK2 activation mechanisms.
  • To explore the pathological implications of PD mutants and therapeutic strategies.

Main Methods:

  • Literature review focusing on structural biology studies of LRRK2.
  • Analysis of LRRK2 domain functions and their regulation.
  • Integration of structural data with knowledge of PD pathogenesis and drug development.

Main Results:

  • Recent structural studies provide a deeper understanding of LRRK2's complex activation, involving intramolecular regulation, dimerization, and membrane binding.
  • The location of PD-related mutations across LRRK2 domains correlates with altered enzymatic activities.
  • Structural insights facilitate the evaluation of LRRK2's role in disease and the design of targeted therapies.

Conclusions:

  • Structural characterization is crucial for deciphering LRRK2 function and dysfunction in Parkinson's disease.
  • Understanding LRRK2 structural dynamics and regulatory mechanisms is key to developing effective PD treatments.
  • Targeting LRRK2 based on its structure offers promising therapeutic avenues for PD.
Keywords:
Leucine-rich-repeat kinase 2Parkinson’s diseaseactivation mechanismintra/intermolecular regulationstructures

More Related Videos

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.1K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

15.2K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.0K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K